United States Pneumococcal Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022

Global Info Research
115 Pages
"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control)."


Scope of the Report:
This report focuses on the Pneumococcal Vaccine in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10

Market Segment by Applications, can be divided into
Child
Adult

There are 17 Chapters to deeply display the United States Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Pneumococcal Vaccine, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Pneumococcal Vaccine market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Pneumococcal Vaccine Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents
1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 PPSV 23
1.2.2 PCV 7/13
1.2.3 PCV 10
1.3 Market Analysis by Applications
1.3.1 Child
1.3.2 Adult
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Profile
2.1.2 Pneumococcal Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Pfizer News
2.2 GSK
2.2.1 Profile
2.2.2 Pneumococcal Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 GSK News
2.3 MSD
2.3.1 Profile
2.3.2 Pneumococcal Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 MSD News
2.4 Sanofipasteur
2.4.1 Profile
2.4.2 Pneumococcal Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Sanofipasteur News
2.5 CDIBP
2.5.1 Profile
2.5.2 Pneumococcal Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 CDIBP News
3 United States Pneumococcal Vaccine Market Competition, by Manufacturer
3.1 United States Pneumococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Pneumococcal Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share
3.4.2 Top 5 Pneumococcal Vaccine Manufacturer Market Share
3.5 Market Competition Trend
4 United States Pneumococcal Vaccine Market Analysis by States
4.1 United States Pneumococcal Vaccine Sales Market Share by States
4.2 United States Pneumococcal Vaccine Sales by States (2012-2017)
4.3 United States Pneumococcal Vaccine Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Pneumococcal Vaccine by Type
5.1 United States Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
5.1.2 United States Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017)
5.2 PPSV 23 Sales Growth and Price
5.2.1 United States PPSV 23 Sales Growth (2012-2017)
5.2.2 United States PPSV 23 Price (2012-2017)
5.3 PCV 7/13 Sales Growth and Price
5.3.1 United States PCV 7/13 Sales Growth (2012-2017)
5.3.2 United States PCV 7/13 Price (2012-2017)
5.4 PCV 10 Sales Growth and Price
5.4.1 United States PCV 10 Sales Growth (2012-2017)
5.4.2 United States PCV 10 Price (2012-2017)
6 United States Market Segmentation Pneumococcal Vaccine by Application
6.1 United States Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
6.2 Child Sales Growth (2012-2017)
6.3 Adult Sales Growth (2012-2017)
7 California Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
7.1 California Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 California Pneumococcal Vaccine Sales and Market Share by Type
7.3 California Pneumococcal Vaccine Sales by Application (2012-2017)
8 New York Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Pneumococcal Vaccine Sales and Market Share by Type
8.3 New York Pneumococcal Vaccine Sales by Application (2012-2017)
9 Texas Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Pneumococcal Vaccine Sales and Market Share by Type
9.3 Texas Pneumococcal Vaccine Sales by Application (2012-2017)
10 Florida Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Pneumococcal Vaccine Sales and Market Share by Type
10.3 Florida Pneumococcal Vaccine Sales by Application (2012-2017)
11 Illinois Pneumococcal Vaccine Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Pneumococcal Vaccine Sales and Market Share by Type
11.3 Illinois Pneumococcal Vaccine Sales by Application (2012-2017)
12 Pneumococcal Vaccine Market Forecast (2017-2022)
12.1 United States Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Pneumococcal Vaccine Market Forecast by States (2017-2022)
12.3 Pneumococcal Vaccine Market Forecast by Type (2017-2022)
12.4 Pneumococcal Vaccine Market Forecast by Application (2017-2022)
13 Pneumococcal Vaccine Manufacturing Cost Analysis
13.1 Pneumococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Pneumococcal Vaccine
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Pneumococcal Vaccine Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2016
14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source


List of Tables and Figures

Figure Pneumococcal Vaccine Picture
Table Product Specifications of Pneumococcal Vaccine
Figure United States Sales Market Share of Pneumococcal Vaccine by Types in 2016
Table Types of Pneumococcal Vaccine
Figure PPSV 23 Picture
Table Major Manufacturers of PPSV 23
Figure PCV 7/13 Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Picture
Table Major Manufacturers of PCV 10
Table United States Pneumococcal Vaccine Sales Market Share by Applications in 2016
Table Applications of Pneumococcal Vaccine
Figure Child Picture
Figure Adult Picture
Figure California Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Pneumococcal Vaccine Type and Applications
Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Pneumococcal Vaccine Type and Applications
Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Pneumococcal Vaccine Type and Applications
Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table Sanofipasteur Pneumococcal Vaccine Type and Applications
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CDIBP Basic Information, Manufacturing Base and Competitors
Table CDIBP Pneumococcal Vaccine Type and Applications
Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure United States Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table United States Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure United States Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2015
Figure United States Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Table United States Pneumococcal Vaccine Price by Manufacturers (2016-2017)
Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2016
Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2017
Figure Top 5 Pneumococcal Vaccine Manufacturer Market Share in 2016
Figure Top 5 Pneumococcal Vaccine Manufacturer Market Share in 2017
Figure United States Pneumococcal Vaccine Sales and Growth (2012-2017)
Table United States Pneumococcal Vaccine Sales by States (2012-2017)
Table United States Pneumococcal Vaccine Sales Market Share by States (2012-2017)
Figure United States 2012 Pneumococcal Vaccine Sales Market Share by States
Figure United States 2016 Pneumococcal Vaccine Sales Market Share by States
Figure United States Pneumococcal Vaccine Revenue and Growth (2012-2017)
Table United States Pneumococcal Vaccine Revenue by States (2012-2017)
Table United States Pneumococcal Vaccine Revenue Market Share by States (2012-2017)
Table United States 2012 Pneumococcal Vaccine Revenue Market Share by States
Table United States 2016 Pneumococcal Vaccine Revenue Market Share by States
Table United States Pneumococcal Vaccine Sales by Type (2012-2017)
Table United States Pneumococcal Vaccine Sales Share by Type (2012-2017)
Table United States Pneumococcal Vaccine Revenue by Type (2012-2017)
Table United States Pneumococcal Vaccine Revenue Share by Type (2012-2017)
Figure United States PPSV 23 Sales Growth (2012-2017)
Figure United States PPSV 23 Price (2012-2017)
Figure United States PCV 7/13 Sales Growth (2012-2017)
Figure United States PCV 7/13 Price (2012-2017)
Figure United States PCV 10 Sales Growth (2012-2017)
Figure United States PCV 10 Price (2012-2017)
Table United States Pneumococcal Vaccine Sales by Application (2012-2017)
Table United States Pneumococcal Vaccine Sales Share by Application (2012-2017)
Figure United States Child Sales Growth (2012-2017)
Figure United States Adult Sales Growth (2012-2017)
Figure California Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure California Pneumococcal Vaccine Sales and Growth (2012-2017)
Table California Pneumococcal Vaccine Sales by Type (2012-2017)
Table California Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table California Pneumococcal Vaccine Sales by Application (2012-2017)
Table California Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure New York Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure New York Pneumococcal Vaccine Sales and Growth (2012-2017)
Table New York Pneumococcal Vaccine Sales by Type (2012-2017)
Table New York Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table New York Pneumococcal Vaccine Sales by Application (2012-2017)
Table New York Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure Texas Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure Texas Pneumococcal Vaccine Sales and Growth (2012-2017)
Table Texas Pneumococcal Vaccine Sales by Type (2012-2017)
Table Texas Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table Texas Pneumococcal Vaccine Sales by Application (2012-2017)
Table Texas Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure Florida Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure Florida Pneumococcal Vaccine Sales and Growth (2012-2017)
Table Florida Pneumococcal Vaccine Sales by Type (2012-2017)
Table Florida Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table Florida Pneumococcal Vaccine Sales by Application (2012-2017)
Table Florida Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure Illinois Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure Illinois Pneumococcal Vaccine Sales and Growth (2012-2017)
Table Illinois Pneumococcal Vaccine Sales by Type (2012-2017)
Table Illinois Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table Illinois Pneumococcal Vaccine Sales by Application (2012-2017)
Table Illinois Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure United States Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022)
Table United States Pneumococcal Vaccine Sales Forecast by States (2017-2022)
Table United States Pneumococcal Vaccine Market Share Forecast by States (2017-2022)
Table United States Pneumococcal Vaccine Sales Forecast by Type (2017-2022)
Table United States Pneumococcal Vaccine Market Share Forecast by Type (2017-2022)
Table United States Pneumococcal Vaccine Sales Forecast by Application (2017-2022)
Table United States Pneumococcal Vaccine Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccine
Figure Manufacturing Process Analysis of Pneumococcal Vaccine
Figure Pneumococcal Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2016
Table Major Buyers of Pneumococcal Vaccine
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

United States Topical Skin Adhesive Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

"Topical skin adhesive is a wound closure device that is fast, precise and easy to use. Topical ski...Read More

United States Hyaluronic Acid Dermal Filler Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

This report studies the Middle East Hyaluronic Acid Dermal Filler market, Hyaluronic Acid Dermal Fil...Read More

United States Capecitabine Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic br...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.